跨国药企财报刚刚告一段落，又迎来了国内药企财报季。本周，多个国内药企密集释放上半年“成绩单”。1、中国生物制药：创新产品收入 78 亿元，同比增长 27.2%8 月 18 日，中国生物制药发布 2025 上半年业绩报告，报告期内：收入 175.7 亿元，同比增长 10.7%；创新产品收入 78.0 亿元，同比增长 27.2%，占到了公司总收入的 44.4%；研发投入 31.9 亿元，占总收入约 ...
Source Link跨国药企财报刚刚告一段落，又迎来了国内药企财报季。本周，多个国内药企密集释放上半年“成绩单”。1、中国生物制药：创新产品收入 78 亿元，同比增长 27.2%8 月 18 日，中国生物制药发布 2025 上半年业绩报告，报告期内：收入 175.7 亿元，同比增长 10.7%；创新产品收入 78.0 亿元，同比增长 27.2%，占到了公司总收入的 44.4%；研发投入 31.9 亿元，占总收入约 ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.